Global Companion Diagnostic Markets Report 2021: Will Personalized Companion Diagnostics Become the Norm for Diagnostics?
February 11, 2021 04:18 ET
|
Research and Markets
Dublin, Feb. 11, 2021 (GLOBE NEWSWIRE) -- The "Companion Diagnostic Markets - the Future of Diagnostics, by Funding Source and Application with Customized Forecasting/Analysis, COVID-19 Updates, and...
Worldwide Industry for Companion Diagnostics to 2024 - The Rising Use of Personalized Medicine is Driving Growth
January 07, 2021 07:58 ET
|
Research and Markets
Dublin, Jan. 07, 2021 (GLOBE NEWSWIRE) -- The "Global Companion Diagnostics Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The companion diagnostics market is poised...
Global Companion Diagnostics Market Growth, Trends, and Forecasts Report 2020-2025: Companies Promoting Personalized Medicine and Targeted Therapy as a New Treatment Option
December 30, 2020 08:43 ET
|
Research and Markets
Dublin, Dec. 30, 2020 (GLOBE NEWSWIRE) -- The "Companion Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The growth of...
Global Alzheimer Diagnostic Testing Devices Pipeline Report 2020 - Stage of Development, Territory, Regulatory Path, Estimated Approval Date, Ongoing Clinical Trials
December 23, 2020 07:28 ET
|
Research and Markets
Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering. "Alzheimer...
Global Pancreatic Cancer Diagnostic Tests Devices Pipeline Assessment Report 2020
December 22, 2020 03:48 ET
|
Research and Markets
Dublin, Dec. 22, 2020 (GLOBE NEWSWIRE) -- The "Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering. ...
Lung Cancer Diagnostic Test Devices Pipeline Assessment Report 2020: Stage of Development, Territory, Regulatory Path, Estimated Approval Date, Ongoing Clinical Trials
December 21, 2020 11:08 ET
|
Research and Markets
Dublin, Dec. 21, 2020 (GLOBE NEWSWIRE) -- The "Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering. "Lung Cancer...
Insights into Companion Diagnostics During the COVID-19 Pandemic - 2020 Market Study
October 21, 2020 08:13 ET
|
Research and Markets
Dublin, Oct. 21, 2020 (GLOBE NEWSWIRE) -- The "Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities" report has been added to ResearchAndMarkets.com's offering. This...
Global Oncology Companion Diagnostic Market Report 2020: Commercial Launch of Drugs that Require CDx Testing Before Prescription has Increased Revenue Generation
October 13, 2020 06:09 ET
|
Research and Markets
Dublin, Oct. 13, 2020 (GLOBE NEWSWIRE) -- The "Oncology Companion Diagnostic Market Size, Share & Trends Analysis Report by Product & Service, by Technology (IHC, NGS), by Disease Type...
Monopar Announces Plan to Advance Development of Novel Triage Test for Severe COVID-19 Utilizing its Patented Technology
August 12, 2020 08:30 ET
|
Monopar Therapeutics Inc.
WILMETTE, Ill., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) today announced its plan to develop a test to potentially triage COVID-19 patients into those likely versus...
US FDA approves Invivoscribe LeukoStrat CDx FLT3 Mutation Assay as CDx and Astellas drug XOSPATA (gilteritinib fumarate) for treatment of AML patients in the US
November 29, 2018 06:00 ET
|
Invivoscribe, Inc.
SAN DIEGO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Invivoscribe is pleased to announce FDA approval of both the LeukoStrat CDx FLT3 Mutation Assay and the Astellas drug, XOSPATA (gilteritinib fumarate),...